Investigational New Drugs

, 27:557 | Cite as

Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol

  • Clovis O. Da Fonseca
  • Julio Thome Silva
  • Igor Rodrigo Lins
  • Marcela Simão
  • Adriano Arnobio
  • Débora Futuro
  • Thereza Quirico-Santos
PHASE I STUDIES

Summary

Background: The aim of this study was to establish a correlation of tumor topography and peritumoral brain edema with the therapeutic response to intranasal administration of perillyl alcohol (POH) in a cohort of patients with recurrent malignant gliomas. Methods: The retrospective study reviewed clinical and neuroradiological data from patients with recurrent malignant gliomas who received intranasal daily administration of POH 440 mg. The following parameters were assessed: demographic characteristics, initial symptoms, overall survival, tumor topography and tumor size, presence of midline shift and extent of peritumoral edema. Statistical analysis was carried out with log rank tests and overall survival as assessed by Kaplan–Meier method including 95% confidence intervals. Results: A cohort of 67 patients included 52 (78%) with glioblastoma (GBM), ten (15%) with anaplastic astrocytoma (AA) and five (7%) with anaplastic oligodendroglioma (AO). Accordingly to tumor topography lobar localization was present in all (5/5) AO; eight (8/10) and 41 GBM patients whereas in the basal ganglia two AA and 11 GBM patients. It was also observed a relation between the tumor size and area of peritumoral brain edema (PTBE). Patients with good therapeutic response showed reduction of tumor size and PTBE area, but poor prognosis was associated with lack of response to treatment and persistence of high PTBE. Patients with tumor in the basal ganglia survived significantly longer than those with lobar gliomas (log rank test, p = 0.0003). Presence of midline shift (>1 cm) was a statistically significant risk factor for shorter survival (log rank test, p = 0.0062) Conclusions: This study suggests that: (1) patients with recurrent gliomas with localization in the basal ganglia survive significantly longer than those with tumors at lobar localization; (2) presence of PTBE contributes to symptoms, likely to be implicated in the morbidity and invading potential of malignant gliomas. These findings support the theory that interaction between glioma cells at distinct brain microenvironment can influence the oncobiological behavior of glioma cells and ultimately to the prognosis.

Keywords

Gliomas Intranasal administration Perillyl alcohol Tumor topography Peritumoral edema Tumor microenvironment 

References

  1. 1.
    Cassoni P, Senetta R, Castellano I, Ortolan E, Bosco M, Magnani I, Ducati A (2007) Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas. Am J Surg Pathol 5:760–769 doi:10.1097/01.pas.0000213433.14740.5d Google Scholar
  2. 2.
    Nutt CL, Mani DR, Betensky RA, Tamoio P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63:1602–1607PubMedGoogle Scholar
  3. 3.
    Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, Christian B, Ruppert J, Bernstein T, Kraus G, Mantil JC (2003) Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 3:227–237 doi:10.1023/A:1025665820001 CrossRefGoogle Scholar
  4. 4.
    Mitchell P, Ellison DW, Mendelow AD (2005) Surgery for malignant gliomas: mechanistic reasoning and slippery statistics. Lancet Neurol 4:413–422 doi:10.1016/S1474-4422(05)70118-6 CrossRefPubMedGoogle Scholar
  5. 5.
    Harpold HL, Alvord EC Jr, Swanson KR (2007) The evolution of mathematical modeling of glioma proliferation and invasion. J Neuropathol Exp Neurol 66:1–9 doi:10.1097/nen.0b013e31802d9000 CrossRefPubMedGoogle Scholar
  6. 6.
    Swanson KR, Bridge C, Murray JD, Alvord EC Jr (2003) Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci 15:1–10 doi:10.1016/j.jns.2003.06.001 CrossRefGoogle Scholar
  7. 7.
    Lefranc F (2007) Glioblastomas are resistant to apoptosis but less resistant to the autophagic process. Bull Mem Acad R Med Belg 162:331–338PubMedGoogle Scholar
  8. 8.
    Ramnarayan R, Dodd S, Das K, Heidecke V, Rainov NG (2007) Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter. J Neurol Sci 15:49–56 doi:10.1016/j.jns.2007.04.003 CrossRefGoogle Scholar
  9. 9.
    Arismendi-Morillo G (2005) Tumoral micro-blood vessels and vascular microenvironment in human astrocytic tumors. A transmission electron microscopy study. J Neurooncol 73:211–217 doi:10.1007/s11060-004-5674-3 CrossRefPubMedGoogle Scholar
  10. 10.
    Kostic A, Mihailovic D, Veselinovic S, Tasic G, Radulovic D, Stefanovic I (2007) Peritumoral edema and karyometric variables in astrocytoma of the brain. J BUON 12:239–243PubMedGoogle Scholar
  11. 11.
    Da Fonseca CO, Landeiro JA, Clark SS, Quirico-Santos T, Da Costa Carvalho MG, Gattass CR (2006) Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol. Surg Neurol 65:S2–S8 doi:10.1016/j.surneu.2005.06.030 CrossRefGoogle Scholar
  12. 12.
    Da Fonseca CO, Masini M, Futuro D, Caetano R, Gattass RC, Quirico-Santos T (2006) Anaplastic oligodendroglioma responding favorably to intranasal delivery of perillyl alcohol: a case report and literature review. Surg Neurol 66:611–615 doi:10.1016/j.surneu.2006.02.034 CrossRefPubMedGoogle Scholar
  13. 13.
    Da Fonseca CO, Schwartsmann G, Fischer J, Nagel J, Futuro D, Quirico-Santos T, Gattass CR (2008) Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas. Surg Neurol 70:259–266CrossRefPubMedGoogle Scholar
  14. 14.
    Da Fonseca CO, Linden R, Futuro D, Gattass CR, Quirico-Santos T (2008) Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol. Arch Immunol Ther Exp (Warsz) 56:267–276 doi:10.1007/s00005-008-0027-0 CrossRefGoogle Scholar
  15. 15.
    Mentrikoski M, Johnson MD, Korones DN, Scott GA (2008) Glioblastoma multiforme in skin: a report of 2 cases and review of the literature. Am J Dermatopathol 30:381–384CrossRefPubMedGoogle Scholar
  16. 16.
    Stadlbauer A, Nimsky C, Gruber S, Moser E, Hammen T, Engelhorn T, Buchfelder M, Ganslandt O (2007) Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol 28:462–469PubMedGoogle Scholar
  17. 17.
    Billottet C, Jouanneau J (2008) Tumor–stroma interactions. Bull Cancer 95:51–56PubMedGoogle Scholar
  18. 18.
    Hoelzinger DB, Demuth T, Berens ME (2007) Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99:1583–1593 doi:10.1093/jnci/djm187 CrossRefPubMedGoogle Scholar
  19. 19.
    Laws ER, Shaffrey ME, Morris A, Anderson FA Jr (2003) Surgical management of intracranial gliomas—does radical resection improve outcome? Acta Neurochir Suppl (Wien) 85:47–53Google Scholar
  20. 20.
    Pavlićević G, Roganović Z (2003) Outcome of surgical treatment of malignant astrocytoma of the brain. Vojnosanit Pregl 60:147–154PubMedGoogle Scholar
  21. 21.
    Pathy S, Jayalakshmi S, Chander S, Singh R, Julka PK, Rath GK (2002) Prognostic factors influencing the outcome of thalamic glioma. Neurol India 50:37–40PubMedGoogle Scholar
  22. 22.
    Gamburg ES, Regine WF, Patchell RA, Strottmann JM, Mohiuddin M, Young AB (2000) The prognostic significance of midline shift at presentation on survival in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 48:1359–1362 doi:10.1016/S0360-3016(00)01410-3 PubMedGoogle Scholar
  23. 23.
    Wick W, Kuker W (2004) Brain edema in neurooncology: radiological assessment and management. Onkologie 27:261–266 doi:10.1159/000077976 CrossRefPubMedGoogle Scholar
  24. 24.
    Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE (1996) Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 27:65–73 doi:10.1007/BF00146086 CrossRefPubMedGoogle Scholar
  25. 25.
    Zhao Y, Xiao A, Dipierro CG, Abdel-Fattah R, Amos S, Redpath GT, Carpenter JE, Pieper RO, Hussaini IM (2008) H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signaling pathway. Glia 56:917–924 doi:10.1002/glia.20667 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Clovis O. Da Fonseca
    • 2
  • Julio Thome Silva
    • 1
  • Igor Rodrigo Lins
    • 2
  • Marcela Simão
    • 1
  • Adriano Arnobio
    • 3
  • Débora Futuro
    • 4
  • Thereza Quirico-Santos
    • 1
  1. 1.Laboratory of Cellular Pathology, Department of Cellular and Molecular Biology, Institute of BiologyFluminense Federal UniversityNiteroiBrazil
  2. 2.Service of Neurosurgery, Department of General and Specialized Surgery, Antonio Pedro University HospitalFluminense Federal UniversityNiteróiBrazil
  3. 3.Unity of Clinical Research, Antonio Pedro University HospitalFluminense Federal UniversityNiteróiBrazil
  4. 4.Department of Pharmaceutical Sciences, School of PharmacyFluminense Federal UniversityNiteróiBrazil

Personalised recommendations